Author Archives: Fred Kahn, M.D, FRCS(C)

CLINICAL ABSTRACT –
Fred Kahn, MD, FRCS(C), Ronaldo Santiago, MD

PURPOSE OF ARTICLE
To Illustrate The Efficacy Of Light Therapy In The Treatment Of Neurological Pathologies.

PATIENT PROFILE:

Currently he is under the care of his family physician, a neurologist, urologist, etc.

He sustained his initial concussion as a child when he fell out of a tree and lost consciousness for an undetermined period of time. A severe whiplash injury occurred in his 20s, accompanied by trauma to the cranium and three years ago, he had another concussion (moderate/severe) when he sustained a blow to the head at work.

He has been on Acyclovir for the past six months, presumably for treatment of Epstein-Barr Syndrome. Symptoms over the past two years persist without relief and include severe dizziness, headaches, insomnia, fatigue and a complete inability to function at all levels. The patient has been unable to work, is relatively immobile, unable to speak and relates a host of additional cognitive symptoms. He has been subjected to ongoing physiotherapy, occupational therapy, speech therapy, numerous specialist consultants and the employment of an extensive variety of therapeutic options, none of which have improved his status.

PHYSICAL EXAMINATION NOVEMBER 19, 2017:

  • The patient moves slowly and has a shuffling gait.
  • His facial expressions are relatively rigid.
  • Despite his current age of 52 years, his appearance and movements resemble someone in their 80s.
  • The patient is right-handed. The right grip is 50 lbs and the left 40 lbs.
  • Lateral abduction of both shoulders is to 90° only and all movements of both shoulders are restricted in varying degrees.
  • Range of motion of the cervical spine with regard to flexion, extension, lateral rotation and lateral flexion is less than 20% of normal and a similar range of motion of the thoracolumbar spine is 25% of normal.
  • Straight leg raising is 50° bilaterally.
  • Range of motion of both hips is minimal.
  • A reverse thoracolumbar scoliosis with the lumbar apex to the right is noted to be present.
  • Varying degrees of tenderness exist over the cervical, thoracic and lumbar spine.
  • The patient speaks slowly and his voice demonstrates minimal volume.
  • He lacks any affect.
  • His speech is hesitant and the sounds are almost unintelligible.
  • His wife acts as an interpreter which is helpful.

INITIAL DIAGNOSIS:

  1. Neurodegenerative Disorder (Multiple System Atrophy)
  2. Parkinson’s Disease.

TREATMENT AT MEDITECH CLINIC:

The patient commenced treatment with Laser Therapy at our clinic, and this was applied over the cervical, thoracic and lumbar spine, along with both shoulder joints. After five treatments to these areas, therapy was extended to the cerebral hemispheres, initially targeting the occipital lobe and eventually including the temporo-parietal and the frontal lobe

After seven days of daily treatment, there was noticeable improvement in his gait. The patient was able to rise from the seated position without help and recovered a relatively normal gait. His sleep problem was completely resolved and he was able to smile and speak in a normal fashion. Comprehension of all verbal communications had been largely restored.

DISCUSSION:

Multiple system atrophy (MSA) is a rare, progressive neurodegenerative disorder characterized by a combination of symptoms that affect both the autonomic nervous system (the part of the nervous system that controls involuntary action such as blood pressure or digestion) and movement. The symptoms reflect the progressive loss of function and apoptosis of nerve cells in the central nervous system.

Autonomic failure symptoms include fainting spells and problems with heart rate, erectile dysfunction and bladder control. Motor impairments (loss of or limited muscle control or movement, or limited mobility) may include tremor, rigidity, and/or loss of muscle coordination as well as difficulties with speech and gait. As these features are similar to Parkinson’s disease, it may be difficult to distinguish these disorders early in the course of the disease.

MSA can be divided into two different types:

  1. the Parkinsonian type (MSA-P), with primary characteristics similar to Parkinson’s disease (such as moving slowly, stiffness, and tremor) along with problems of balance, coordination, and autonomic nervous system dysfunction, and;
  2. the Cerebellar type (MSA-C), with primary symptoms featuring ataxia (problems with balance and coordination), difficulty swallowing, speech abnormalities or a quavering voice, and abnormal eye movements (“cerebellar” reflects a part of the brain involved with coordination)

The cause of MSA is unknown. There is noted accumulation of the protein alpha-synuclein in glial cells that support nerve cells in the brain, primarily oligodendroglia which produces myelin in the central nervous system. The same protein also accumulates in Parkinson’s disease, but within the nerve cells itself as opposed to the supporting glial cells in MSA1.

There are no known treatments to delay the progressive neurodegeneration associated with MSA and at this time there is no known cure. Current treatments are mostly supportive and convey minimal clinical benefit. In this case, the patient was referred to physiotherapists, occupational therapists, acupuncture practitioners, and an integrative medicine practitioner who detected the Epstein-Barr viral (EBV) antigen in his system. Presumably this is the reason he was placed on Acyclovir, which he felt did not convey any benefit.

Currently there are no studies that mention a connection between MSA and EBV, however the latter has been linked to an increased potential to develop Multiple Sclerosis (MS). For some individuals, Levodopa may improve motor function, however improvement is minimal and diminishes as the disease progresses.

Using cell models of MSA, scientists were able to show that both damage to the mitochondria (cellular “power plants”) and the generation of abnormal alpha-synuclein aggregates may contribute to the development of MSA. In a study conducted by Blin, et al, a significant age-related decrease in the activity of mitochondrial respiratory chain complex I was observed, supporting the hypothesis of a wide-spread mitochondrial complex I deficiency in PD and MSA as compared to age-matched controls, who only showed age-related deficiency. Deficits in complex III and IV activity (which includes cytochrome c oxidase) was also observed, but which was restricted to a few patients2.

Many investigators believe that Laser Therapy for brain disorders is one of the most important medical applications of Light Therapy. It is well accepted that with the overall aging of the general population, together with ever lengthening life spans, that Dementia, Alzheimer’s, and Parkinson’s disease will become a global health problem and even after many years of research, no drug has been developed to benefit these neurodegenerative disorders3. Laser Therapy is a non-invasive, light-based therapy that utilizes a combination of red and infrared light sourced from red and infrared LED’s and laser diodes and for over 30 years has been effectively used in the treatment of many medical conditions, including musculoskeletal, dermatological problems, wound healing and more recently, the treatment of neurological conditions.

Photon particles of light are absorbed by the mitochondria through cytochrome c oxidase, causing a photo-dissociation of nitric oxide from cytochrome c oxidase resulting in increased cellular ATP levels. The dissociated nitric oxide levels also promote vasodilation and improve arterial perfusion.

Given that previous studies show mitochondrial involvement in both PD and MSA, there would be several key advantages for the use of Laser therapy for PD and MSA. Although in its infancy, with the bulk of results still at the pre-clinical “proof of concept” stage, Laser Therapy has the potential to develop into a safe and effective neuroprotective treatment for patients with Parkinson’s disease and other neurodegenerative diseases such as MSA. If Laser Therapy was applied at an early stage of the disease process it could without doubt stop progression of the disease and begin healing of the cells, along with the regenerative process based on its neuromodulation and neuroprotective effects. Over time this should achieve the objective of restoring the function and morphology of the neurons and other intracranial tissue resulting in significant improvement with regard to all clinical signs and symptoms4. Moreover, Laser therapy, with the accompanying lack of adverse side-effects, is amenable to use in conjunction with other treatments when available. Laser Therapy, as a specific treatment for MSA and other neurological conditions, is completely safe, simple to apply and in the context of a bleak future, for MSA patients in particular, offers a safe and specific therapeutic approach. This will not only extend the affected individual’s life span but also improve the quality of life for these patients and hopefully a return to normal activity levels.

CONCLUSION:

This patient’s level of improvement after one week of daily treatments including November 19-24, was in excess of 70%. He was walking and communicating in a relatively normal fashion and required no assistance to accomplish this.

For logistical reasons, he returned to his home in Florida where his wife will continue to treat him on alternate days according to the protocols developed at the Meditech Rehabilitation Centre. He will return in four weeks for re-evaluation and continuing treatment under our direct supervision for an additional two weeks.

This case demonstrates the dramatic effect of Laser Therapy in the treatment of neurological conditions. It should be noted that the patient stated that he expects to return to work in March 2018.

REFERENCES:

  1. Multiple System Atrophy Fact Sheet | National Institute of Neurological Disorders and Stroke.https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Multiple-System-Atrophy
  2. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP, Billé F, Figarella D, Coulom F, Pellissier JF, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson’s disease and multiple system atrophy. J Neurol Sci. 1994 Aug;125(1):95-101.
  3. Michael R. Hamblin. Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical 6 (2016) 113–124
  4. Johnstone DM, Moro C, Stone J, Benabid AL, Mitrofanis J, Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer’s and Parkinson’s Disease. Front Neurosci. 2015; 9: 500.

A Commentary to All Healthcare Providers, Regulatory Bodies & Patients:

Arthritis

There are many forms of arthritis, the most common being degenerative osteoarthritis.

Some facts excerpted from The World Health Organization literature indicate several shocking realities.*

  • Arthritis is considered to be the nation’s number one crippling disease and the most common chronic disease of people over the age of 40.
  • According to the Center for Disease Control and Prevention, an estimated 46 million adults in the United States have been told by a physician that they have some form of arthritis, including degenerative osteoarthritis, rheumatoid arthritis, gout, lupus or psoriatic arthritis.
  • By 2030, a startling 67 million Americans age 18 years or older are projected to have arthritis—a 45% increase from current statistics.
  • The average age that arthritis begins is 47 years, with 1 in 2 Americans over age 65 dealing with some form of arthritis.
  • The cost of arthritis due to lost wages, medical treatment and other related expenses can run an individual over $150,000 in expenses over their lifetime.

These facts are significant–the solutions less so. Physicians are prone to prescribing analgesics, anti-inflammatory medications and muscle relaxants or inject cortisone, xylocaine and a variety of lubricating solutions. All of these mask symptoms temporarily, however they do not provide a permanent solution.

Laser Therapy, a relatively new technology perfected by Meditech International Inc. in Toronto, Canada currently offers up-to-date, professional therapeutic systems along with Home Units for utilization by individuals who have not had their problems resolved by conventional and traditional methods, including surgical procedures. Symptoms generally improve immediately following the institution of Laser Therapy. Applying treatment in a cumulative fashion stimulates the reduction of symptoms over time resulting in the patient’s return to a normal range of activities without the utilization of analgesics or other medications.

Unfortunately Laser Therapy is seldom mentioned as a solution as it is not covered by the codes, insurance programs, national health care systems and other mainstream regulatory bodies. The reasons: medicine is slow to change and vested interests will go to great lengths to provide protection for their products, regardless of the lack of value induced.
At this point in time, it must be clearly understood that the BioFlex Laser Therapy Systems offer ongoing relief of symptoms of arthritis in all areas of the body by restoring the normal morphology and function of the cells.

In addition, the therapy provides a potent anti-inflammatory effect and boosts the immune system while restoring the integrity of the cells. Regeneration of cartilage is also a part of this process, which is administered in a pain-free and completely safe manner.

Comparatively speaking, the cost is minimal and each treatment stimulates the healing process to a higher level, making surgical interventions such as arthroscopy, joint replacements and spinal surgeries in the majority of instances redundant.

As time progresses the patient can discard all pharmaceuticals and focus on a healthy diet and activities such as swimming, stretching and walking to achieve a complete recovery.
The facts regarding the efficacy of Laser Therapy are undeniable. At our Meditech Rehabilitation Clinics, this reality can be seen many times over the course of each day and the changes which patients often describe as “a miracle” have come to be an almost standard outcome.

A recent example of results achievable is the case of Jerome Williams, also known as “J.Y.D.” or Junk Yard Dog, a brand label that he has acquired over a stellar ten year career in the NBA.
Jerome presented for treatment at one of our clinics in April and immediately noted improvement. He acquired a Home System and a month later, a Professional System for stationary therapy at his home in Las Vegas, Nevada. The results achieved have been so dramatic that at the age of 44, he has returned to a professional career in basketball in the newly formed 3D League.

Once again, his play is outstanding and in addition he is continuing his long-standing career with the NBA as a goodwill ambassador of the league. J.Y.D. is also involved in many charitable and educational organizations in his post-NBA career. I am pleased to state that he is a perfect example of what can be accomplished with the intelligent application of BioFlex Laser Therapy, a technology that can replace all current and conventional treatments for arthritis.

For additional information, contact Meditech International Inc., Toronto, Canada 416-251-1055, or review our website www.bioflexlaser.com.

LASER THERAPY IN THE TREATMENT OF NEUROLOGICAL PATHOLOGIES

ABSTRACT

This patient demonstrates the benefits of Laser Therapy in the treatment of the neurological problems that typically present at our clinic. It cannot always be accurately determined how much benefit is obtained secondary to Laser Therapy, but in this case, prior to February 2017, the patient’s status had plateaued completely. Subsequent to the initiation of Laser Therapy in February 2017, his ability to speak and the improvement in his visual fields, in view of the absence of other factors, must therefore be attributed to Laser Therapy.

CASE PROFILE:

  • Chiari Malformation-Left Temporal Lobe with spontaneous intracranial bleeding episode. (December 31, 2015)
  • Emergency Craniotomy. (January 1, 2016)

MEDICAL HISTORY:

The patient is a 22-year-old male, who had been diagnosed with an intracranial arteriovenous malformation in the left temporo-parietal area, diagnosed two years prior to treatment at our facility.

At that time, he had sustained an intracranial hemorrhage with a subsequent rise in intracranial pressure. The situation required an emergency craniotomy in order to evacuate the hematoma in the left posterior temporo-parietal lobe.

An MRI post-surgery revealed a discrete area of encephalomalacia involving the parietal operculum and the posterior temporal lobe extending to the left side of the brain.
As a result of the surgery, the patient continued to have significant visual disturbances, memory loss, cognitive issues and aphasia. His ability to speak was markedly reduced, along with comprehension at many levels. An automated visual field perimetry study performed post-craniotomy revealed a total inferior right homonymous quadrantanopsia, consistent with the cortical damage that had occurred.

PHYSICAL EXAMINATION (February 2017):

Aside from the visual impairment and aphasia, there was a modicum of findings with regard to other abnormalities.
There was a loss of normal curvature of the cervical spine and moderate tenderness over this area.

DIAGNOSIS:

  • Chiari Malformation-Left Temporal Lobe with spontaneous intracranial bleeding episode.
  • Emergency Craniotomy.
  • Visual Field Impairment/Aphasia, along with Moderate Cognitive Impediments
  • DISCUSSION:

    The patient received a total of four Laser Therapy sessions involving the cervical spine, brainstem and cerebellum at the Meditech Rehabilitation Clinic beginning February 21, 2017. As he lived at a distance from the clinic, his caregivers were trained on the utilization of the Home System and continued the treatment subsequently at regular intervals. The areas treated included the cerebral hemispheres and the cervical spine.

    After several weeks of treatment, the patient’s attendance at university was resumed.

    Six months post-initiation of Laser Therapy, the patient had a follow-up appointment with his ophthalmologist. An automated visual field perimetry study was performed and revealed a 10% decrease in scotoma. The quadrantanopsia did not cross the vertical midline.

    Enclosed in this communication are his visual fields prior to starting Laser Therapy and six months after continuing treatment. His ophthalmologist was impressed with the improvement noted considering that the trauma had occurred almost two years prior to initiating Laser Therapy. His initial quadrantanopsia had been considered to be permanent.

    As his improvement in speech and vision are continuing to move forward, the patient was advised to continue with both the cranial and cervical Laser Therapy under our supervision.

    INTRODUCTION:

    For over 30 years, Laser Therapy has been effectively used in the treatment of many medical conditions, including musculoskeletal, dermatological problems, wound healing and more recently, the treatment of neurological conditions.

    The technology has been utilized for over 40 years and over the past two decades, has made significant progress. Laser Therapy is a non-invasive, light-based therapy that applies a combination of red and infrared light sourced from red and infrared LED’s and laser diodes.

    Photon particles are absorbed by the mitochondria through cytochrome c oxidase, causing a photodissociation of nitric oxide from cytochrome c oxidase resulting in increased cellular ATP levels. The dissociated nitric oxide levels also promote vasodilation and improve arterial perfusion.

    Transcranial Laser Therapy has been demonstrated to significantly improve outcomes in patients of all types. Lampl et al wrote that “Although the mechanism of action of infrared laser therapy for stroke may not be completely understood, infrared laser therapy is a physical process that can produce biochemical changes at the tissue level. The putative mechanism involves stimulation of ATP formation by mitochondria and may also involve prevention of apoptosis in the ischemic penumbra and enhancement of neurorecovery mechanisms.”1

    Apart from ischemic heart disease, stroke (CVA) is the leading cause of death worldwide. The current approved treatment is to apply tissue plasminogen activator within 3 hours of onset of a CVA. Although this method is effective in clearing blood clots, the narrow time window that exists for effective treatment limits treatment options for the majority of stroke victims.
    Laser Therapy has been investigated as an alternative treatment for CVA and has been shown to have a neuromodulatory and neuroprotective effect, while regulating many biological processes.

    MECHANISMS OF ACTION

    Photon particles are absorbed by the cerebrospinal fluid and distributed throughout the cranium, including the ventricles. These confer a significant neuromodulation effect. The particles of energy are also absorbed by the arterial, venous and lymphatic systems and are thereby transported to the fluid surrounding the central nervous system and the spinal cord. Additional benefit is transmitted by direct irradiation of the soft tissues and the skeletal system of the area involved.

    1Lampl Y. Zivin J.A. Fisher M. Lew R. Welin L. Dahlof B. Borenstein P. Andersson B. Perez J. Caparo C. Ilic S. Oron U. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1) Stroke. 2007; 38:1843–1849

    Automated Goldmann Visual Fields (December 23, 2016)

    • Right Homonymous Inferior Quadrantanopsia
    • This is a typical “pie on the floor” appearance in a visual field that conveys involvement of the optic radiation as it traverses the left temporo-parietal lobe. Note complete scotoma of the left lower quarter visual field.

    Automated Goldmann Visual Fields (August 18, 2018)

    • Right inferior quadrantanopsia
    • Scotoma is not homonymous in this visual field. Note 10% improvement in both visual fields with sparing of the central visual field

Beware Before Swallowing!

The article below is a typical example of the inappropriate dispensing of medications simply for the easy relief of symptoms. The latter may not even be a significant problem and it would be more appropriate for the physician to deal with these matters by assessing the patient more extensively prior to resorting to prescribing. A few minutes of discussion can most often avoid the “instant gratification” provided by writing a prescription.

According to current trends, cannabis may soon be over prescribed and in many situations, unnecessarily so, yet the downside of that approach is less hazardous than the many toxic chemicals so casually dispensed.

Before you swallow beware! Instant gratification in the form of a pill is seldom a permanent solution and in some cases may be a deadly one.

Fred Kahn, MD, FRCS(C)

Antipsychotics, not anti-insomnia

National Post (Latest Edition)16 Jun 2017
Sharon Kirkey

Recently, after morning rounds seeing patients admitted to his hospital through emergency, Dr. David Juurlink tweeted: “Can the next doctor wanting to prescribe Seroquel for sleep, just not?”

Of the roughly 20 patients he had seen that morning, four had been prescribed Seroquel, an antipsychotic, for insomnia.

Seroquel and its generics aren’t approved as sleeping pills. Quetiapine, the active ingredient, has been officially approved in Canada for schizophrenia, bipolar disorder and major depression only.

Yet drug-safety experts are growing increasingly alarmed by the drug’s use as a doctor-prescribed nightcap for insomnia, with a 10- fold increase in quetiapine prescriptions for sleep problems in Canada between 2005 and 2012 alone.

Quetiapine is sedating. Like over- the- counter sleep aids, it makes people drowsy. But it also comes with a multitude of potential side effects, according to experts.

These side effects include an odd sensation of tension and restlessness (akathisia), Parkinson’s- like tremors and movement abnormalities, weight-gain, high blood sugar, new or worsening diabetes and, in rare cases, heart arrhythmia that can cause sudden cardiac death. A recent Health Canada review linked quetiapine and other so- called “atypical” antipsychotics to an increased risk of sleep apnea — breaks in breathing during sleep.

Juurlink, a clinical toxicologist at Sunnybrook Health Sciences Centre in Toronto, said quetiapine can also cause a particularly nasty complication known as neuroleptic malignant syndrome, a rare but potentially life- threatening reaction to antipsychotics or major tranquillizers. “Over the last decade, I have seen several patients who have had quetiapine as part of, or one of the contributing causes to NMS,” said Juurlink, whose frustrated tweet to doctors last week was a repeat of one he has sent before.

“I’ve certainly seen people who have been diagnosed with Parkinson’s disease that I’m confident were from quetiapine,” he added. “It’s getting to the point now where, when I admit a patient with Parkinson’s, I reflexively look at their other medications to see, ‘are they on quetiapine?’ ”

pills
According to drug market research firm IMS Brogan, of the 33 million prescriptions for tranquillizers dispensed by Canadian retail drugstores in 2016, one quarter — 8.3 million — were for quetiapine.

Doctors say the drug is being prescribed in low- dose formulations to people with no underlying psychiatric conditions, the majority for sleep. University of B.C. researchers found that 58 per cent of B.C. quetiapine prescriptions in 2010 were for the 25 mg tablet. The dose range for the approved disorders is 150 to 800 mg per day.

“It’s popping up as a patient’s typical medication for insomnia all the time,” says Kamloops emergency physician Dr. Ian Mitchell. “It’s not well supported by any science for use in sleep, it has significant side effects and yet it’s massively prescribed.”

“Seroquel is not benign,” Dr. David Gardner, a professor of psychiatry and pharmacology at Dalhousie University said in an email. “It may be more dangerous than our standard sleeping pills, but without research we cannot know or quantify its risks.”

It’s not clear how antipsychotics have become such a big thing for sleep. But observers point to aggressive marketing and industryfunded “opinion leaders” who’ve described quetiapine as a “mild, not harmful” drug that seems to help with sleep.

marijuana

Some users swear by it. “Seroquel helps me for sleep when nothing else will,” according to one online reviewer. “The only bad thing is 30 ( minutes) to one hour after taking it, I’m starving!!” Others describe feeling spacey and foggy the next morning.

Juurlink said quetiapine might shorten sleep latency — the time it takes to fully fall asleep — by a few minutes. It can also make people less aware of their “nocturnal awakenings” than they might otherwise have been. It’s a potent antihistamine, like diphenhydramine, the active ingredient in Benadryl and other “nighttime” cold remedies.

“But what’s really driving this is a societal expectation that we should all get eight hours of sleep a night, a pill is a way to go about it, and the willingness of some providers to accede to requests for sleeping pills,” Juurlink said.

While quetiapine has proven safe and effective for approved conditions, and most of the side effects have been reported during highdose treatment, side effects such as tardive dyskinesia — abnormal movements of the face and jaw — have been reported with low-dose regimens as well, according to the UBC Therapeutics Initiative.

Abuse of quetiapine is also a growing problem, with people inhaling or injecting crushed or dissolved tablets.

Mitchell says it’s hard to explain the “inherent hypocrisy” of the massive prescribing of an antipsychotic for insomnia, while medical leaders are warning doctors to be wary of prescribing marijuana for sleep.

“I’m not asking people to smoke a joint in a nursing home for sleep, that’s not what this is about,” he said. “But there may be some alternatives to some of the damaging medications that are out there, or ways to replace them with cannabis.”

PROFILE: NIILO SCHONFELD

October 3, 2017

Niilo is a Toronto-born international Long Driving Competitor who has established a world-wide reputation. He has won a number of international competitions including Mexico, South Africa, etc. His strengths are his work ethic, competitive drive and discipline. Since his first long drive competition six years ago he now ranks among the best long drive golfers internationally.
nilo_sm
Niilo spends countless hours training in the gym and at the range. At all times he keeps sight of his goal to become the World Long Driving Champion. He possesses great natural athletic ability and this has been enhanced by many hours in the gymnasium and improving his psychological focus.

Niilo’s efforts have been facilitated over the past 10 years by the ongoing use of the BioFlex Laser Therapy System. He is now using his third device and states unequivocally it has been helpful in keeping his joints, neck and back, pain-free. This is a great asset in an endeavor where injuries invariably end the careers of most competitors at an early age.

At Meditech we take great pride in supporting Niilo’s endeavors and will continue to maintain his health status at an optimal level in order that he may achieve his final objective: a World Championship in International Golf Ball Distance Driving.

Some Statistics
• Club Head Speed: 140mph
• Ball Speed: 210mph
• Longest drive: 435 yds.
• Equipment utilized: Heads – Geek Golf, No Brainer
Shafts – Execution, Triple X Flex

A Passing Thought

Simple Solutions Are Best – the reason!

− not only because they are simple but logical. Generally, they have a scientific basis and are effective − and so it is with the treatment of pain. Conventional methods of managing pain consist of modulating symptoms, much like venting smoke from a burning fire. Usually, pharmaceuticals in varying doses are utilized to achieve this objective, which is only temporary at best and not devoid of adverse effects.

With the utilization of Laser Therapy, one treats the cause of the pain or the existing pathological condition. The logical sequence – the pain disappears, much as smoke will vanish when you put out the fire.

Many people simply defy logic and as scientific solutions evolve, it is sometimes absurd how simple the process can be. Subsequently, people will state, “Why didn’t I think of that?”. The fact is, they didn’t and therein lies the problem.

In our society, independent thought and creativity are stifled by an overwhelming number of factors including excessive regulations, the challenges of technology and expanding governments, not to mention a flawed educational system. All these matters will need to change if our civilization is to survive.

A Commentary

The article enclosed “Looking For the Contradictions” is an outstanding commentary that not only challenges the status quo but makes an extremely sound case for reviewing current medical thinking and practice, encompassing all areas from nutrition to cancer therapy. Medical education has not been reviewed since the Flexner report funded by The Rockefeller Foundation, composed between the years 1915 to 1925. This would clearly indicate that further review would be appropriate at this point in time.

Health care systems today are largely controlled by governments, insurance companies, and Wall Street corporations with additional and often adverse influence exerted from the pharmaceutical sector.

It takes a great deal of courage for people such as Dr. Kendrick and others to attempt to bring logic into the many false concepts currently in vogue. Many myths are disseminated on the basis of conscious or subliminally motivated greed.

Personally, I take this opportunity to compliment Dr. Kendrick for writing this article, which everyone concerned with healthcare should read. It is apparent that our culture has deviated sharply from the concepts of integrity, creativity and independent thought. In essence the individual has been destroyed and replaced by governments whose main objectives are to get elected and increase taxes, insurance companies whose primary interest is the bottom line and pharmaceutical companies that are similarly motivated, having long given up the challenging task of developing specific curative products.

When will all this stop and how can the negative process going forward be reversed? I welcome your suggestions and trust that you will enjoy the article by Dr. Kendrick.

https://drmalcolmkendrick.org/2017/08/09/what-causes-heart-disease-part-xxxiv-part-thirty-four/

Arthritis

There are many forms arthritis, the most common being degenerative osteoarthritis. Some facts excerpted from The World Health Organization literature indicate a number of shocking realities.*

  • Arthritis is considered to be the nation’s number one crippling disease and the most common chronic disease of people over the age of 40.
  • According to the Center for Disease Control and Prevention, an estimated 46 million adults in the United States have been told by a physician that they have some form of arthritis, including degenerative osteoarthritis, rheumatoid arthritis, gout, lupus or psoriatic arthritis.
  • By 2030, a startling 67 million Americans age 18 years or older are projected to have arthritis—a 45% increase from current statistics.
  • The average age that arthritis begins is 47 years, with 1 in 2 Americans over age 65 dealing with some form of arthritis.
  • The cost of arthritis due to lost wages, medical treatment and other related expenses can run an individual over $150,000 in expenses over their lifetime.

These facts are significant–the solutions less so. Physicians are prone to prescribing analgesics, anti-inflammatory medications and muscle relaxants or inject cortisone, xylocaine and a variety of lubricating solutions. All of these mask symptoms temporarily, however they do not provide a permanent solution.

Laser Therapy, a relatively new technology perfected by Meditech International Inc. in Toronto, Canada currently offers up-to-date, professional therapeutic systems along with Home Units for utilization by individuals who have not had their problems resolved by conventional and traditional methods, including surgical procedures. Symptoms generally improve immediately following the institution of Laser Therapy. Applying treatment in a cumulative fashion stimulates the reduction of symptoms over time resulting in the patient’s return to a normal range of activities without the utilization of analgesics or other medications.

Unfortunately Laser Therapy is seldom mentioned as a solution as it is not covered by the codes, insurance programs, national health care systems and other mainstream regulatory bodies. The reasons: medicine is slow to change and vested interests will go to great lengths to provide protection for their products, regardless of the lack of value induced.

At this point in time, it must be clearly understood that the BioFlex Laser Therapy Systems offer ongoing relief of symptoms of arthritis in all areas of the body by restoring the normal morphology and function of the cells. In addition the therapy provides a potent anti-inflammatory effect and boosts the immune system while restoring the integrity of the cells. Regeneration of cartilage is also a part of this process, which is administered in a pain-free and completely safe manner. Comparatively speaking, the cost is minimal and each treatment stimulates the healing process to a higher level, making surgical interventions such as arthroscopy, joint replacements and spinal surgeries in the majority of instances redundant. As time
progresses the patient can discard all pharmaceuticals and focus on a healthy diet and activities such as swimming, stretching, walking to achieve a complete recovery.

The facts regarding the efficacy of Laser Therapy are undeniable. At our Meditech Rehabilitation Clinics, this reality can be seen many times many times over the course of each day and the changes which patients often describe as “a miracle”, have come to be the standard outcome.

A recent example of results achievable is the case of Jerome Williams, also known as “].Y.D.” or Junk Yard Dog, a brand label that he has acquired over a stellar ten year career in the NBA. Jerome presented for treatment at one of our clinics in April and immediately noted improvement. He acquired a Home System and a month later, a Professional System for stationary therapy at his home in Las Vegas, Nevada. The results achieved have been so dramatic that at the age of 44, he has returned to a professional career in basketball in the newly formed 3D League.

Once again, his play is outstanding and in addition he is continuing his long-standing career with the NBA as a good will ambassador of the league. J.Y.D. is also involved in many charitable and educational organizations in his post-NBA career. I am pleased to state that he is a perfect example of what can be accomplished with the intelligent application of BioFlex Laser Therapy, a technology that can replace all current and conventional treatments for arthritis. For additional information, contact Meditech International Inc., Toronto, Canada (416-251-1055), or review our website (www.bioflexlaser.com).

Junk Yard Dog Sees The Light

‘Jerome ‘JYD’ Williams has two BioFlex Laser Therapy Systems… and he’s protecting them like a Junk Yard Dog with a bone.’

Former NBA star and currently on the Power Team of the Big 3 Basketball League, Jerome “Junk Yard Dog” (JYD) Williams relies on BioFlex Laser Therapy to eliminate the pain in his knees. The latter was not only chronic but at times acute, preventing Jerome from playing basketball, the sport that is relevant to his sense of completeness in life. After just two months of self-administered therapy, the pain was relieved to the degree that he was able to resume his professional basketball career in the 3-on-3 league, demonstrating his high level abilities while playing along with other notable former NBA stars. He travels with a BioFlex Personal System on the road and uses a Professional System at home.

treatment1

pic1

Top: Jerome being treated with the BioFlex DUO+ Treatment Array
Bottom: Jerome performs in the 3up League

Jerome attended Georgetown University on a full athletic scholarship and as a further testament of his tremendous athletic ability, was picked in the 1st round of the NBA’s 1996 Draft by the Detroit Pistons. His impressive career as an NBA Power Forward spanned nine years with Detroit, the Toronto Raptors, the Chicago Bulls and the New York Knicks. . At all times, he demonstrated his ability to be a team player and in 2000, he led the league in high rebounding percentages and was ranked third overall in offensive ratings.

Jerome Williams brought his talent, heart and extraordinary passion to the court and holds an impressive 6.6 points per game and 6.4 rebounds. His NBA career included a total of 587 games. Nicknamed “JYD” for his extraordinary work ethic by his teammates in Detroit, he furthered the JYD persona into his own brand.

JYD was excited to join the Toronto Raptors in 2000; so much so that he passed up a morning flight, electing instead to brave a brutal February snowstorm and drive from Detroit to Toronto the night before. He wanted to make certain that he was in the city in time for his first practice with his new teammates.

Toronto fans were jubilant on his arrival. The greetings at the Air Canada Centre by the fans when he played as a Raptor for the first time were overwhelming. Toronto Raptor fans continued to show their love even after JYD was traded, always providing a standing ovation whenever he was on the court.

His impressive NBA career and work ethic, matched by his stellar character, continues to be demonstrated by his involvement in many charitable organizations and his work as a good will ambassador for the NBA.

He initiated an after-school program in the Brewster community in Detroit “right in the middle of the projects”, devoting extensive time and effort to this task.

In an effort to bring his unparalleled knowledge and understanding of the game of basketball to underdeveloped nations, he joined “Basketball Without Borders”. Jerome’s post-NBA career is highlighted by numerous community service awards over the years. He was honoured with a National Home Team award by the Fannie Mae Foundation, was invited to the White House and led a drive to raise money for the Toronto District School Board to buy books for students. His passion to give back to the community was recognized by the NBA principals and he was awarded the NBA Community Assist Award in May 2005. A father of four, he currently serves as Chairman of the non-profit organization, JYD Project Inc. Although Jerome celebrated many firsts as an NBA player, he was the first role player, featuring his own tennis shoe and a Sprite deal.

Incidentally, he is not the first NBA star to rely on BioFlex Laser Therapy systems but he is no doubt the most grateful and enthusiastic individual with regard to the effectiveness of the treatment. As he recalls, many of his Toronto Raptor teammates, including Vince Carter, Tracy McGrady, etc. relied upon this amazing technology to treat their many injuries. Feel free to enter Jerome’s DoggPound but with the BioFlex Systems in his healthcare arsenal, don’t ever expect to hear the Junk Yard Dog whimper.

From my interactions with Jerome, he is an outstanding human being, a basketball player for the ages, a solid family man and someone who cares about everyone inhabiting our planet. His existence makes the world a better place. I am certain he will bring all of his stellar qualities to the Big 3 League and entertain everyone that has the privilege and opportunity to watch him perform.

dr_kahn_jerome_williams

Jerome Williams with Dr Kahn at the Meditech Downtown Clinic

Traumatic Brain Injury– A Commentary

RETHINK-REDO-REWIRED-BOOK-COVER-1150x1721Anthony Aquan-Assee, M.Ed. recently presented me with a book titled “Rethink, Redo, Rewired”. The book is an excellent treatise devoted to the course of recovery from a series of major brain injuries. The book describes Anthony’s prolonged struggles to regain his life, along with the many impediments and inappropriate therapies that litter the path to recovery.

On pages 65-68, he describes his experience with Laser Therapy, which played the major role in his return to normal health. Personally, I can state unequivocally that all cases of traumatic brain injury treated at our clinic, more than 80% achieve this level of recovery and the remainder are improved in varying degrees. During the year 2016, we treated over 500 cases of traumatic brain injury and this year, our expectations are that we will exceed 800 patients treated at the Meditech Rehabilitation Clinics.

The book confirms that Anthony has made a relatively complete recovery from the injuries sustained during the past decade. He is fully functional and once again making contributions to our society in a normal fashion.

His case is just one example of the numerous patients that we return to a normal health status after struggling for many years in the black void of traumatic brain injury.

To learn more or purchase a book, visit https://anthonyaquan-assee.com